Managing rectal cancer: The Dutch experience

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 423-426

  Peeters, K C M J ^a   Kapiteijn, E ^a   van de Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Quality control; Rectal cancer; Surgery; TME

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSECTION; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM CANCER; RECTUM SURGERY; RECURRENCE RISK; RETROSPECTIVE STUDY; REVIEW; STANDARDIZATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

HUMANS; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0041827267     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00513.x     Document Type: Review

References (14)

1. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996; 39: 323-8.
2. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
3. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or Postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993; 36: 564-72.
4. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336: 980-7.
5. Camma C, Giunta M, Fiorica F et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. J Am Med Assoc 2000; 284: 1008-15.
6. Heald RJ. A new approach to rectal cancer. Br J Hosp Med 1979; 22: 277-81.
7. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-82.
8. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.
9. Aitken RJ. Mesorectal excision for rectal cancer. Br J Surg 1996; 83: 214-6.
10. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002; 89: 1008-13.
11. Houbiers JG, Brand A, van de Watering LM et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-8.
12. Martling AL, Holm T, Rutqvist LE et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-6.
13. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 1995; 75: 2269-75.
14. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.